NRx Pharmaceuticals to Engage Investors at EF Hutton Annual Global Conference

NRx Pharmaceuticals

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) will attend the EF Hutton Annual Global Conference on May 15, 2024, at The Plaza Hotel, New York City.

The company’s leadership, including Chairman and Chief Scientist Prof. Jonathan Javitt and Chief Business Officer Matthew Duffy, will conduct one-on-one sessions with investors.

Registration for interested participants is available online.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Arbutus Biopharma to Present Key Findings at EASL Congress 2024